Publications by authors named "Alexander Schepart"

Claim this Profile
E
Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma.
Bhavesh Shah, Rickard Sandin, Yun Liu, Laura R Bobolts, Yannan Hu, Alexander Schepart

Clinicoecon Outcomes Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-enabled tools in cardiovascular medicine: A survey of current use, perceptions, and challenges.
Alexander Schepart, Arianna Burton, Larry Durkin, Allison Fuller, Ellyn Charap

Cardiovasc Digit Health J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and health care resource use of patients at risk for wild-type transthyretin amyloid cardiomyopathy identified by machine learning model.
Marianna Bruno, Richard Sheer, Casey Reed, Alexander Schepart, Radhika Nair

J Manag Care Spec Pharm· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying diagnosis support systems in electronic health records to identify wild-type transthyretin amyloid cardiomyopathy risk.
Connor Willis, Alexandre H Watanabe, Justin Hughes, Kimberly Nolen, Jason O'Meara, Alexander Schepart

Future Cardiol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population.
Jamieson M Bourque, Alexander Schepart, Rahul Bhambri, Adam Castaño, Alex O'Brien

Am J Cardiol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis